Education at mammogram impacts skin cancer awareness
October 11th 2018Patients that schedule regular mammograms could easily be encouraged to screen for melanoma via self-skin examination when given instructions at their breast cancer screenings, according to a recent study. This type of intervention program could be an effective strategy to increase skin cancer awareness.
The state of off-label drug laws
October 11th 2018Congress has proposed two bills that are designed to promote a "scientific exchange" between drug manufacturers and physcians. As a result, drug manufacturers may be able to share clinical data and non-FDA-approved uses of drugs with healthcare providers in the future.
José Raúl Montes, M.D., sings a metaphor for injectable synergy
October 3rd 2018When hurricanes Irma and Maria hit Puerto Rico in September 2017, the connections Dr. José Raúl Montes, an oculoplastic surgeon and frequent speaker at dermatology meetings, said that the connections he made through the years with peers and patients helped him stay afloat. Speaker and oculoplastic surgeon, José Raúl Montes, M.D., discusses how his love for music and passion for connection have lead him to train others on the proper use of injectables.
Ethical dilemmas for physicians in Catholic healthcare organizations
September 28th 2018Can clinicians working for Catholic health care organizations prescribe the birth control pill for acne? A recent article discusses the ethical and legal problems these clinicians face when patients request to be treated with oral contraceptives.
Vulvar diseases are skin diseases
July 27th 2018It might not be the first place dermatologists look, but diseases of the vulva are skin conditions. An itchy, sore vulva can be caused by a number of different skin conditions, said Dr. Gayle Fischer in a presentation given at the AAD Summer Meeting.
It may be time for act two in atopic dermatitis research
June 13th 2018For some patients with moderate to severe atopic dermatitis, the combination of dupilumab and corticosteroids may be necessary to control flares, a new study shows. Dupilumab is a proven treatment for AD, so where do we go from here? A physician writing in BJD suggests predictive modeling.